• J. Am. Acad. Dermatol. · May 2021

    Practice Guideline

    National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.

    • Joel M Gelfand, April W Armstrong, Stacie Bell, George L Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D Dommasch, Steven R Feldman, Dafna Gladman, Leon Kircik, Mark Lebwohl, Vincent Lo Re, George Martin, Joseph F Merola, Jose U Scher, Sergio Schwartzman, James R Treat, Abby S Van Voorhees, Christoph T Ellebrecht, Justine Fenner, Anthony Ocon, Maha N Syed, Erica J Weinstein, George Gondo, Sue Heydon, Samantha Koons, and Christopher T Ritchlin.
    • Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics and Center for Clinical Epidemiology and Biostatistics Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Joel.Gelfand@pennmedicine.upenn.edu.
    • J. Am. Acad. Dermatol. 2021 May 1; 84 (5): 1254-1268.

    ObjectiveTo update guidance regarding the management of psoriatic disease during the COVID-19 pandemic.Study DesignThe task force (TF) includes 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation staff. Clinical questions relevant to the psoriatic disease community were informed by inquiries received by the National Psoriasis Foundation. A Delphi process was conducted.ResultsThe TF updated evidence for the original 22 statements and added 5 new recommendations. The average of the votes was within the category of agreement for all statements, 13 with high consensus and 14 with moderate consensus.LimitationsThe evidence behind many guidance statements is variable in quality and/or quantity.ConclusionsThese statements provide guidance for the treatment of patients with psoriatic disease on topics including how the disease and its treatments affect COVID-19 risk, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 (including novel vaccination), and what they should do if they develop COVID-19. The guidance is a living document that is continuously updated by the TF as data emerge.Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…